Action Meso retweetledi

Perioperative Pembrolizumab for Early-Stage NSCLC nej.md/3WK7LMs
Nivolumab and Chemotherapy in Stage III Lung Cancer nej.md/3pjpj63
Editorial: Perioperative Immunotherapy — A KEY toward Improved Outcomes for Early-Stage Lung Cancer? nej.md/45eIZXK
English












































